.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Argus Health
UBS
Boehringer Ingelheim
Chinese Patent Office
Dow
Accenture
US Department of Justice
Medtronic
Express Scripts

Generated: September 25, 2017

DrugPatentWatch Database Preview

Betamethasone acetate; betamethasone sodium phosphate - Generic Drug Details

« Back to Dashboard

What are the generic sources for betamethasone acetate; betamethasone sodium phosphate and what is the scope of betamethasone acetate; betamethasone sodium phosphate patent protection?

Betamethasone acetate; betamethasone sodium phosphate
is the generic ingredient in two branded drugs marketed by Merck Sharp Dohme and Luitpold, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty-six drug master file entries for betamethasone acetate; betamethasone sodium phosphate. Six suppliers are listed for this compound.

Summary for Generic Name: betamethasone acetate; betamethasone sodium phosphate

Tradenames:2
Patents:0
Applicants:2
NDAs:2
Drug Master File Entries: see list66
Suppliers / Packagers: see list6
Clinical Trials: see list4,054
Therapeutic Class:Inflammatory Bowel Disease Agents
Drug Prices:see low prices
DailyMed Link:betamethasone acetate; betamethasone sodium phosphate at DailyMed

Pharmacology for Ingredient: betamethasone acetate; betamethasone sodium phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Luitpold
BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE
betamethasone acetate; betamethasone sodium phosphate
INJECTABLE;INJECTION090747-001Jul 31, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Merck Sharp Dohme
CELESTONE SOLUSPAN
betamethasone acetate; betamethasone sodium phosphate
INJECTABLE;INJECTION014602-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: betamethasone acetate; betamethasone sodium phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck Sharp Dohme
CELESTONE SOLUSPAN
betamethasone acetate; betamethasone sodium phosphate
INJECTABLE;INJECTION014602-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Teva
Harvard Business School
McKesson
Johnson and Johnson
US Army
Cantor Fitzgerald
AstraZeneca
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot